Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14)
SGX:T14
Holding SG:T14?
Track your performance easily
T14 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.54 - $2.48
Previous Close$2.46
Volume85.90K
Average Volume (3M)124.10K
Market Cap
$3.91B
Enterprise Value$3.55B
Total Cash (Recent Filing)¥2.88B
Total Debt (Recent Filing)¥257.91M
Price to Earnings (P/E)13.9
Beta0.48
Next Earnings
Aug 15, 2024EPS EstimateN/A
Last Dividend Ex-Date
Jul 02, 2024Dividend Yield6.41%
Share Statistics
EPS (TTM)0.18
Shares Outstanding768,873,076
10 Day Avg. Volume227,780
30 Day Avg. Volume124,101
Standard Deviation0.09
R-Squared0.02
Alpha0.00437
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S News
PremiumCompany Announcements
Tianjin Pharma Unveils 2024 Shareholder-Centric Plan
PremiumCompany Announcements
Tianjin Pharmaceutical Approves Key Resolutions
PremiumCompany Announcements
Tianjin Pharma Confirms Proceeds Management
PremiumCompany Announcements
Tianjin Pharma Completes Biannual Risk AssessmentPremiumCompany Announcements
Tianjin Pharma Approves Funds for Cash Flow
PremiumCompany Announcements
Tianjin Pharma Completes Temporary Funds Allocation
PremiumCompany Announcements
Tianjin Pharma Doubles Stake in Finance ArmPremiumCompany Announcements
Tianjin Pharma Announces Joint Venture ExtensionOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.03% Mutual Funds
<0.01% Other Institutional Investors
99.96% Public Companies and
Individual Investors
T14 FAQ
What was Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s price range in the past 12 months?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S lowest share price was $1.54 and its highest was $2.48 in the past 12 months.
What is Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s market cap?
Currently, no data Available
When is Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s upcoming earnings report date?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s upcoming earnings report date is Aug 15, 2024 which is 10 days ago.
How were Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s earnings last quarter?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S released its earnings results on Apr 29, 2024. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of N/A by $0.07.
Is Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S overvalued?
According to Wall Street analysts Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s price is currently Overvalued.
Does Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S pay dividends?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S pays a Annually dividend of $0.18 which represents an annual dividend yield of 6.41%. See more information on Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S dividends here
What is Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s EPS estimate?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S have?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S has 200,000,000 shares outstanding.
What happened to Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s price movement after its last earnings report?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S reported an EPS of $0.07 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.485%.
Which hedge fund is a major shareholder of Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S?
Currently, no hedge funds are holding shares in SG:T14
---
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Zhong Xin Pharmaceutical Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.
---
Technical Analysis
Advanced Blockchain AG
―
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
―
---